Confirming Pathological Vertebral Fractures with Leptomeningeal Metastasis

Diagnostic Approach

The diagnostic approach for confirming pathological vertebral fractures with leptomeningeal metastasis involves CSF cytology demonstrating tumor cells, ideally obtained from two separate lumbar punctures if the first is negative, combined with correlation of typical MRI findings and clinical neurological signs 1, 2, 3

The American College of Radiology recommends reviewing contrast-enhanced sequences systematically for characteristic findings of both pathological fractures and leptomeningeal disease, including pathological fracture features on T1-weighted images and leptomeningeal metastasis patterns on post-gadolinium 3D T1-weighted and FLAIR sequences 2, 3, 4
The National Comprehensive Cancer Network suggests that CSF cytology should be performed with specific technical requirements, including collecting ≥10 mL CSF volume and processing fresh samples within 30 minutes when feasible 1, 2
The European Society for Medical Oncology recommends using Papanicolaou and Giemsa staining for cytological analysis and applying immunocytochemical staining for epithelial and melanocytic markers when material is available 1, 2

The American College of Radiology recommends using ≥1.5-Tesla field strength with gadolinium at 0.1 mmol/kg, injected 10 minutes before acquisition, and obtaining MRI before lumbar puncture when feasible 1, 2
The National Comprehensive Cancer Network suggests that slice thickness should be 1mm for optimal sensitivity and that contrast-enhanced T1-weighted and FLAIR sequences provide the highest sensitivity (66-98%) for leptomeningeal disease 1, 2, 3, 4

The European Society for Medical Oncology recommends that high certainty diagnosis requires positive CSF cytology plus typical MRI findings, while presumptive diagnosis is acceptable for treatment initiation when typical Type A, B, or C MRI patterns exist with characteristic neurological signs, even with negative CSF after two attempts 1, 2, 3, 4